WHC is still in active development. Read this to understand our approach.
depiction of NLPRAJRHRHZCQQ-UHFFFAOYSA-N.svg
isomerdesign

Epibatidine

Verificar en isomerdesign

drugmap

[125I]epibatidine

Verificar en drugmap

drugmap

[125I]epibatidine

Verificar en drugmap

wiki

Epibatidine

Verificar en wiki

Data

InChI: InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2

Sinónimos: Tocris-0684, KBioGR_000603, KBioSS_000603, (R)-2-(6-Chloro-pyridin-3-yl)-7-aza-bicyclo[221]heptane, CMI 477, 152378-30-8, SCHEMBL316977,( inverted exclamation markA)-Epibatidine, SR-01000597620, (1S,2S,4R)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane, [3H]epibatidine, 7-Azabicyclo(2.2.1)heptane, 2-(6-chloro-3-pyridinyl)-, (1S-exo)-, 148152-66-3, [125I]EPIBATIDINE, BSPBio_001263,CHEMBL6623, CMI 488, CHEMBL298517,Epibatidine, 140111-52-0, 208/210 Epibatidine, (1S-exo)-2-(6-Chloro-3-pyridinyl)-7-azabicyclo(2.2.1)heptane, ZINC967913, BDBM50143320, (-)-1-epidatidine, (1S,2S,4R)-Epibatidine, AC1L1AYB, NLPRAJRHRHZCQQ-UHFFFAOYSA-N, [3H]EPIBATIDINE, AC1Q3PYA, GTPL5348

Estimated data

Solubilidad: -2.054 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 68.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.